Atara Biotherapeutics Inc Net Asset Quality Index
Atara Biotherapeutics Inc net asset quality index. Atara Biotherapeutics Inc (ATRA) has a Net Asset Quality Index of -121.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $30.17 Million minus total liabilities of $66.80 Million yields net assets of $-36.63 Million. A higher index indicates a stronger, lower-leverage balance sheet. See ATRA net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Atara Biotherapeutics Inc (2012–2024)
Net asset quality index of Atara Biotherapeutics Inc from 2012 to 2024. This chart shows how Atara Biotherapeutics Inc's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at -121.4%, representing net assets of $-36.63 Million against total assets of $30.17 Million USD. Check ATRA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Atara Biotherapeutics Inc Net Asset Quality Index by Year (2012–2024)
Atara Biotherapeutics Inc net asset quality index by year from 2012 to 2024. The table below presents the year-by-year Net Asset Quality Index for Atara Biotherapeutics Inc from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Atara Biotherapeutics Inc (ATRA) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -89.2% | $-97.28 Million | $109.10 Million | $206.38 Million | ▼ -29.2 pp |
| 2023 | -60.0% | $-99.23 Million | $165.50 Million | $264.74 Million | ▼ -93.6 pp |
| 2022 | 33.6% | $126.64 Million | $376.42 Million | $249.78 Million | ▼ -26.1 pp |
| 2021 | 59.7% | $279.61 Million | $468.13 Million | $188.51 Million | ▼ -18.9 pp |
| 2020 | 78.6% | $462.34 Million | $588.12 Million | $125.78 Million | ▼ -6.2 pp |
| 2019 | 84.8% | $290.78 Million | $342.94 Million | $52.16 Million | ▼ -1.7 pp |
| 2018 | 86.5% | $338.86 Million | $391.84 Million | $52.98 Million | ▲ +4.8 pp |
| 2017 | 81.7% | $177.86 Million | $217.78 Million | $39.91 Million | ▼ -14.5 pp |
| 2016 | 96.1% | $253.74 Million | $263.91 Million | $10.18 Million | ▼ -0.8 pp |
| 2015 | 97.0% | $315.10 Million | $324.98 Million | $9.88 Million | ▼ -0.3 pp |
| 2014 | 97.2% | $103.18 Million | $106.12 Million | $2.94 Million | ▲ +118.5 pp |
| 2013 | -21.3% | $-11.02 Million | $51.83 Million | $62.84 Million | ▲ +65.6 pp |
| 2012 | -86.9% | $-3.73 Million | $4.29 Million | $8.02 Million | — |